• Advertise
  • About us
  • Terms and Conditions
  • Contact us
Wednesday, May 13, 2026
Australian Times News
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia
No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia
No Result
View All Result
Australian Times News
No Result
View All Result
Home News

Controversial drug should not be hard to come by says Palmer

Politician imports and supplies Trumps miracle drug to Australian stockpile.

Inge Swain by Inge Swain
16-05-2020 13:32
in News
Image by stevepb on Pixabay

Image by stevepb on Pixabay

Politician and businessman Clive Palmer has hit out at the Australian government for their handling of the current Covid-19 pandemic, specifically targeting their stance on the use of the drug hydroxychloroquine, which he has imported into the country at scale.

The drug, which has been in us for a long time, initially as a prophylactic treatment for malaria, has sprung to prominence in recent weeks after it was linked with being a treatment for the coronavirus.

This move led to Palmer, one of the richest men in Australia, obtaining permission from Australia’s drugs regulator to import both the drug and the materials required to produce it.

See the timeline of Hydroxychloroquine use and Coronavirus on this easy to follow infographic. #COVID19Aus #coronavirus https://t.co/z4q1bmXR71

— Clive Palmer (@CliveFPalmer) May 3, 2020

Patients finding hydroxychloroquine hard to source Despite his bold move people who use the pharmaceutical for treatment of conditions like Lupus and rheumatoid arthritis are finding it hard to obtain.

It seems as if due to its suddenly raised profile, hydroxychloroquine stocks in Australia have been severely impacted, creating a situation where people who need to use it for anything other than Corona related treatment are not able to source it.

“It is important that Australians that have been using the drug to treat malaria, lupus and autoimmune diseases over the last 40 years will not have any difficulty in acquiring the drug,” Palmer said.

See Dr Zelenko outline the Politics & Profit motives behind the campaign against Hydroxychloroquinehttps://t.co/2J1zhiXQBD#coronavirus #COVID__19 #Hydroxychloroquin

— Clive Palmer (@CliveFPalmer) May 2, 2020

In turn, infectious diseases Professor Peter Collignon told The Guardian, “If Palmer has truly donated this quantity to the stockpile, and it’s sitting there while the evidence is showing there’s not much chop for it treating Covid-19, the sensible thing to do would be to see what else can we use this supply for.”

AlsoRead...

Svitla Systems

Svitla Systems acquires Australia’s Kiandra IT to expand Global Engineering Footprint and Accelerate AI-Driven delivery

11 May 2026
How Clevero is helping Australian Service Businesses compete with Enterprises on a Fraction of the Budget

How Clevero is helping Australian Service Businesses compete with Enterprises on a Fraction of the Budget

28 April 2026

Trump’s influence muddies the water

It would appear as though the drug is in the middle of a financial and political war, a situation not made any easier by Donald Trump’s jumping on the Hydroxychloroquine bandwagon recently.

How unproven claims of a coronavirus "cure" got radically amplified by Fox News and Silicon Valley. https://t.co/eyRxIsrKC4

— Kathleen (@Kmba26) May 14, 2020

Quite how the situation resolves itself remains to be seen, but, one thing is certain, if Palmer has indeed imported the drug in the quantities he suggests then Australians should not be having any issues accessing it. According to Palmer he has imported enough supplies to provide 33 million doses of the drug and that his stash has all been made available to the national stockpile.

Tags: COVID-19
DMCA.com Protection Status

SUBSCRIBE to our NEWSLETTER

[mc4wp_form id=”2384248″]

Don't Miss

Svitla Systems acquires Australia’s Kiandra IT to expand Global Engineering Footprint and Accelerate AI-Driven delivery

by Pauline Torongo
11 May 2026
Svitla Systems
Business & Finance

Acquisition marks Svitla’s entry into the Australian market and strengthens capabilities in low-code, Microsoft technologies, and enterprise software engineering.

Read moreDetails

Residential Healthcare Practices: Revolution or Evolution?

by Pauline Torongo
11 May 2026
Residential Healthcare Practices: Revolution or Evolution?
Lifestyle

President Bill Lutz’s "revolution" was born from his background in fine dining, which instilled a disciplined, customer-focused approach.

Read moreDetails

Medicana Health Group launches HPV vaccination campaign to support cervical cancer prevention

by Pauline Torongo
28 April 2026
Medicana Health Group launches HPV vaccination campaign to support cervical cancer prevention
Health & Wellness

The Türkiye-based healthcare group has introduced a new awareness campaign focused on HPV vaccination, regular check-ups and early detection, with...

Read moreDetails

How Clevero is helping Australian Service Businesses compete with Enterprises on a Fraction of the Budget

by Pauline Torongo
28 April 2026
How Clevero is helping Australian Service Businesses compete with Enterprises on a Fraction of the Budget
Business & Finance

By consolidating CRM, scheduling, workflow automation, invoicing, reporting, and client communications into a single platform, Clevero gives smaller operators the...

Read moreDetails

How CJAM Group is building 1,100 homes across Southeast Queensland

by Pauline Torongo
24 March 2026
How CJAM Group is building 1,100 homes across Southeast Queensland
Lifestyle

The CJAM Group founder is quietly building a 1,100+ home pipeline, with projects in Hervey Bay and Toowoomba, using a...

Read moreDetails

Design Without Compromise: Where Gutter Protection Meets Modern Architecture

by Fazila Olla-Logday
20 March 2026
Design Without Compromise: Where Gutter Protection Meets Modern Architecture
Business & Finance

Design without compromise by integrating gutter protection seamlessly into modern architecture. Discover how innovative gutter systems enhance your home’s aesthetics...

Read moreDetails

How WageSafe Secured Australia’s Most Reputable Retail Business Among Its Premium Clients

by Fazila Olla-Logday
12 March 2026
How WageSafe Secured Australia’s Most Reputable Retail Business Among Its Premium Clients
at

Learn how WageSafe helps businesses stay compliant with payroll and wage regulations through reliable monitoring, risk management, and expert support—protecting...

Read moreDetails
Load More

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status

  • About us
  • Write for Us
  • Advertise
  • Contact us
  • T&Cs, Privacy and GDPR
No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status

No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status